Zurcher Kantonalbank (Zurich Cantonalbank) Kiniksa Pharmaceuticals, Ltd. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$17.63 - $21.74 $11,706 - $14,435	664 Added 9.64%	7,555 $149,000
Q4 2023 Jan 30, 2024	SELL	$14.37 - $19.07 $1,724 - $2,288	-120 Reduced 1.71%	6,891 $120,000
Q3 2023 Oct 25, 2023	SELL	$13.62 - $20.2 $4,630 - $6,868	-340 Reduced 4.63%	7,011 $121,000
Q2 2023 Aug 07, 2023	SELL	$10.44 - $16.48 $3,361 - $5,306	-322 Reduced 4.2%	7,351 $103,000
Q1 2023 May 08, 2023	BUY	$10.7 - $15.79 $18,125 - $26,748	1,694 Added 28.33%	7,673 $82,000
Q4 2022 Feb 01, 2023	SELL	$11.42 - $17.05 $29,349 - $43,818	-2,570 Reduced 30.06%	5,979 $89,000
Q2 2022 Aug 09, 2022	BUY	$7.6 - $11.41 $10,526 - $15,802	1,385 Added 19.33%	8,549 $83,000
Q4 2021 Feb 01, 2022	BUY	$10.39 - $15.15 $55,347 - $80,704	5,327 Added 289.98%	7,164 $84,000
Q3 2020 Nov 06, 2020	BUY	$15.21 - $25.53 $27,940 - $46,898	1,837 New	1,837 $28,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$33.1 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.42 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

97.5K
Shares

$2.13 Million
0.11% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$860,794
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$654,000
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account